Rubius Therapeutics, Inc. (NASDAQ: RUBY) today announced that it has signed a purchase and sale agreement for the acquisition of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE